Effect of BETY on Biopsychosocial States Associated With Chronic Pain in Rheumatic Individuals.
Investigation of the Effects of BETY on Biopsychosocial Status, Functionality, Mood and Quality of Life of Individuals Diagnosed With Rheumatism and Related to Chronic Pain: A Retrospective Controlled Study
1 other identifier
interventional
300
1 country
1
Brief Summary
No study has been found in the literature investigating the effectiveness of an innovative exercise approach defined on a biopsychosocial basis and having its own original scale on individuals with rheumatism over the years. The aim of this retrospective study was to determine the effects of the Cognitive Exercise Therapy Approach on the biopsychosocial conditions related to chronic pain; functionality, mood and quality of life of individuals with rheumatism diagnosis and to examine the effectiveness of BETY as a routine exercise approach by presenting the results compared with the control group.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Aug 2017
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2023
CompletedFirst Submitted
Initial submission to the registry
November 22, 2024
CompletedFirst Posted
Study publicly available on registry
November 25, 2024
CompletedDecember 2, 2025
December 1, 2025
6 years
November 22, 2024
December 1, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
BETY-Biopsychosocial Questionnaire (BETY-BQ):
it is a 30-item Likert-type scale developed through repeated statistics of feedback from rheumatic individuals who have participated in exercise sessions for many years, expressing the healing characteristics. It evaluates the individual from a biopsychosocial perspective with the subheadings of pain, functionality-fatigue, mood, sociability, sexuality and sleep. It is scored between 0 and 120. BETY-BQ evaluates the individual from a holistic perspective with six subheadings: pain (5 items), functionality (9 items), mood (10 items), sociability (3 items), sexuality (2 items) and sleep (1 item). A high score indicates a low biopsychosocial status.
3 months
Secondary Outcomes (3)
Health Assessment Questionnaire (HAQ)
3 months
Hospital Anxiety Depression Scale (HADS)
3 months
Short Form - 36 (SF-36)
3 months
Study Arms (2)
Cognitive Exercise Therapy Approach (Bilişsel Egzersiz Terapi Yaklaşımı-BETY)
EXPERIMENTAL3 days a week for 3 months
Home exercise program
ACTIVE COMPARATORFor 3 months
Interventions
Individuals with rheumatism were included in BETY sessions after the first session, which included functional gain with function-focused trunk stabilization exercises for their complaints and chronic pain management training based on neuroscience. BETY sessions included function-focused trunk stabilization exercises, chronic pain management, mood information management (dance therapy - authentic movement) as innovative. Individuals were included in a separate session of sexual information management and sleep education. 3 days a week for 3 months
Exercises have been shown and a brochure has been given The individuals in this group were mostly individuals from out of town who were given home exercise recommendations directed by a rheumatologist.
Eligibility Criteria
You may qualify if:
- \- Patients who were diagnosed as Ankylosing spondylitis (1984 modified New York criteria, RA (2010 ACR/EULAR criteria), PsA (2006 CASPAR criteria), SLE (2012 Systemic Lupus International Collaborating Clinics criteria), SSc (2013 ACR/EULAR criteria), pSS (American-European Consensus Group criteria), OA (1986 ACR criteria) and FMS (2016 ACR criteria)
You may not qualify if:
- Patients who had severe cognitive problems
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Eastern Mediterranean Universitylead
- Hacettepe Universitycollaborator
Study Sites (1)
Hacettepe University
Ankara, Samanpazar, 06100, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Aykut Ozçadırcı
Hacettepe University
- PRINCIPAL INVESTIGATOR
Nur Banu Karaca, MSc. PT.
Hacettepe University
- PRINCIPAL INVESTIGATOR
Orkun Tüfekçi, MSc. PT.
Hacettepe University
- PRINCIPAL INVESTIGATOR
Aysima Barlak
Hacettepe University
- STUDY DIRECTOR
Ali Akdoğan, Prof. Dr.
Hacettepe University
- STUDY DIRECTOR
Sedat Kiraz, Prof. Dr.
Hacettepe University
- STUDY CHAIR
Edibe Unal, Prof. Dr.
Hacettepe University
- PRINCIPAL INVESTIGATOR
Sevim Oksüz, PhD. PT.
Eastern Mediterranean University
- STUDY DIRECTOR
Şule Apraş Bilgen, Prof. Dr.
Hacettepe University
- STUDY DIRECTOR
Robert D. Gerwin, MD.
Johns Hopkins University
- STUDY DIRECTOR
Rinnie Geenen, Prof. Dr.
Utrecht University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Asst. Prof. Dr.
Study Record Dates
First Submitted
November 22, 2024
First Posted
November 25, 2024
Study Start
August 1, 2017
Primary Completion
August 1, 2023
Study Completion
August 1, 2023
Last Updated
December 2, 2025
Record last verified: 2025-12